Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In utero stem cell transplantation.

Magnus Westgren1

  • 1Professor, Karolinska Institute, Head of Fetal Medicine, Karolinska University Hospital, Stockholm, Sweden. magnus.westgren@klinvet.ki.se

Seminars in Reproductive Medicine
|November 24, 2006
PubMed
Summary

In utero stem cell transplantation offers a promising therapeutic approach for congenital, hematological, metabolic, and immunological disorders. This technique may allow transplantation without chemotherapy, advancing fetal medicine into a therapeutic field.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
Same author

Prospective Double-Blind Randomized Study of Single Dose Bone Marrow-Derived Mesenchymal Stromal Cells versus Placebo for Steroid-Refractory Acute Graft-Versus-Host Disease.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2025
Same author

Clinical Trials of Fetal Therapy With Continuing Neonatal Interventions: Legal Requirements and Customary Procedures Regarding Parental Consent. The BOOSTB4 Trial as a Case Study.

Prenatal diagnosis·2025
Same author

Distinct Tissue-Dependent Composition and Gene Expression of Human Fetal Innate Lymphoid Cells.

European journal of immunology·2024
Same author

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.

BMJ open·2024
Same author

Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review.

Prenatal diagnosis·2023

Area of Science:

  • Regenerative Medicine
  • Fetal Medicine
  • Immunology

Background:

  • Congenital, hematological, metabolic, and immunological disorders pose significant challenges in patient management.
  • Current treatment options may be limited, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To provide an overview of in utero stem cell transplantation.
  • To explore the potential of stem cell transplantation across histoincompatibility barriers without chemotherapy.
  • To discuss the implications for fetal medicine.

Main Methods:

  • Review of animal models for in utero stem cell transplantation.
  • Analysis of human experience with fetal stem cell transplantation.

Main Results:

Related Experiment Videos

  • Successful in utero stem cell transplantation is demonstrated in various models.
  • Potential for transplantation across histoincompatibility barriers without chemotherapy is highlighted.

Conclusions:

  • In utero stem cell transplantation represents a significant advancement in managing various disorders.
  • Development of efficient intrauterine stem cell treatment can transform fetal medicine into a therapeutic specialty.